Hinge Bio, Inc. — Form D/A

Hinge Bio, Inc. of BURLINGAME, CA, a company, filed a Form D amendment with the SEC on 2020-04-28. The offering totals $19.0M, of which $18.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Daniel J CaponDirectorBurlingame, CA
Malcolm L GefterDirectorBurlingame, CA
J. Misha PetkevichDirectorBethesda, MD
Carin M RollinsDirectorBurlingame, CA
Samuel Misha SaksDirectorBurlingame, CA
William D UngerDirectorBurlingame, CA
Carin M RollinsExecutive OfficerBurlingame, CA
Miriam D SiekevitzExecutive OfficerBurlingame, CA
John Misha PetkevichDirectorBurlingame, CA
Alex E SilversteinDirectorBurlingame, CA
Malcolm E GefterDirectorBurlingame, CA
Jeffrey Misha Long-McGieDirectorBurlingame, CA
Harold E Selick, PhDDirectorBurlingame, CA
Harold E Selick, PhDExecutive OfficerBurlingame, CA
Miriam Misha SiekevitzExecutive OfficerBurlingame, CA
Malcolm GefterDirectorBurlingame, CA
William Misha UngerDirectorBurlingame, CA
Daniel CaponDirectorBurlingame, CA
Daniel CaponExecutive OfficerBurlingame, CA
Carin RollinsDirectorBurlingame, CA
Carin RollinsExecutive OfficerBurlingame, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-01-15D$40.8M$30.6M
2021-02-01D/A$18.0M$18.0M
2021-01-14D/A$18.0M$12.7M
2021-01-07D$18.0M$10.3M
2020-02-27D$19.0M$18.2M

More